ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH ROSENBLATT M.D.

Endocrinology, Diabetes Metabolism

8,279

$1.15M

607
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 50%

$139
Average prescription price

Avg: $144

DAVID MOLL M.D.

Endocrinology, Diabetes Metabolism

8,027

$810K

495
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 50%

$101
Average prescription price

Avg: $144

JOEL MILLER M.D.

Endocrinology, Diabetes Metabolism

7,068

$795K

651
570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 50%

$113
Average prescription price

Avg: $144

DAVID DOMENICHINI M.D.

Endocrinology, Diabetes Metabolism

6,515

$1.1M

567
463 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 50%

$169
Average prescription price

Avg: $144

SAUL NEUMAN MD

Endocrinology, Diabetes Metabolism

6,481

$710K

382
330 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 50%

$110
Average prescription price

Avg: $144

KORT KNUDSON MD

Endocrinology, Diabetes Metabolism

6,089

$954K

535
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$157
Average prescription price

Avg: $144

BRUCE WAINER MD

Endocrinology, Diabetes Metabolism

5,786

$417K

344
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 50%

$72
Average prescription price

Avg: $144

JOSEPH ROSA M.D.

Endocrinology, Diabetes Metabolism

5,704

$701K

500
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 50%

$123
Average prescription price

Avg: $144

MARIA GUOTH MD

Endocrinology, Diabetes Metabolism

5,365

$559K

382
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$104
Average prescription price

Avg: $144

ADAM MAYERSON M.D.

Endocrinology, Diabetes Metabolism

4,932

$745K

572
494 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 50%

$151
Average prescription price

Avg: $144

THOMAS JONES MD

Endocrinology, Diabetes Metabolism

4,885

$325K

300
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 50%

$67
Average prescription price

Avg: $144

GLENN RICH M.D.

Endocrinology, Diabetes Metabolism

4,702

$474K

364
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 50%

$101
Average prescription price

Avg: $144

RICHARD KAYNE MD

Endocrinology, Diabetes Metabolism

4,398

$452K

418
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 50%

$103
Average prescription price

Avg: $144

JUDITH CASTILLO MD

Endocrinology, Diabetes Metabolism

4,220

$642K

384
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$152
Average prescription price

Avg: $144

PHILIP GOLDBERG MD

Endocrinology, Diabetes Metabolism

4,031

$898K

504
424 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$223
Average prescription price

Avg: $144

LATHA DULIPSINGH MD

Endocrinology, Diabetes Metabolism

3,893

$611K

376
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$157
Average prescription price

Avg: $144

PATRICK MCDERMOTT M.D.

Endocrinology, Diabetes Metabolism

3,866

$485K

300
267 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 50%

$125
Average prescription price

Avg: $144

GREGORY BOMBASSEI MD

Endocrinology, Diabetes Metabolism

3,770

$590K

312
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 50%

$157
Average prescription price

Avg: $144

WOLF ERLICH MD

Endocrinology, Diabetes Metabolism

3,697

$349K

348
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 50%

$94
Average prescription price

Avg: $144

EGILS BOGDANOVICS M.D.

Endocrinology, Diabetes Metabolism

3,657

$613K

407
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 50%

$168
Average prescription price

Avg: $144

STEPHEN QUEVEDO M.D.

Endocrinology, Diabetes Metabolism

3,640

$589K

350
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 50%

$162
Average prescription price

Avg: $144

THELMA BATIANCILA MD

Endocrinology, Diabetes Metabolism

3,619

$262K

244
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 50%

$72
Average prescription price

Avg: $144

LIQUN SONG M.D.

Endocrinology, Diabetes Metabolism

3,453

$510K

351
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 50%

$148
Average prescription price

Avg: $144

JORGE DIEZ MD

Endocrinology, Diabetes Metabolism

3,353

$696K

439
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 50%

$207
Average prescription price

Avg: $144

DANIELLE BENAVIV-MESKIN MD

Endocrinology, Diabetes Metabolism

3,260

$478K

296
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 50%

$147
Average prescription price

Avg: $144

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank